Americans pay some of the highest drug costs in the world, disproportionately footing the bill for research and development that has saved and improved countless lives.
A skewed pricing system is hard to decipher, with astronomical list prices, rebates to certain customers and a thicket of rules around generics and market competition.
Meanwhile, Canada, the United Kingdom and other countries negotiate far lower drug prices for access to their massive national health systems.
Two popular remedies, bandied about for years, are to allow administrators of the Medicare Part D prescription drug benefit to negotiate prices with pharmaceutical companies, or to let Americans import drugs from Canada.
Both have their shortcomings.
Read the entire piece HERE
Photo Credit: Getty Images